Aim: This prospective clinical study aimed to evaluate whether it would be possible to reduce the rate of re-excisions using CMOS technology, a specimen radiography system (SRS) or digital breast tomosynthesis (DBT) compared to a conventional full field digital mammography (FFDM) system. Material and Method: Between 12/2012 and 2/2013 50 patients were diagnosed with invasive breast cancer (BI-RADS™ 5). After histological verification, all patients underwent breast-conserving therapy with intraoperative imaging using 4 different systems and differing magnifications: 1. Inspiration™ (Siemens, Erlangen, Germany), amorphous selenium, tungsten source, focus 0.1 mm, resolution 85 µm pixel pitch, 8 lp/mm; 2. BioVision™ (Bioptics, Tucson, AZ, USA), CMOS technology, photodiode array, flat panel, tungsten source, focus 0.05, resolution 50 µm pixel pitch, 12 lp/mm; 3. the Trident™ specimen radiography system (SRS) (Hologic, Bedford, MA, USA), amorphous selenium, tungsten source, focus 0.05, resolution 70 µm pixel pitch, 7.1 lp/mm; 4. tomosynthesis (Siemens, Erlangen, Germany), amorphous selenium, tungsten source, focus 0.1 mm, resolution 85 µm pixel pitch, 8 lp/mm, angular range 50 degrees, 25 projections, scan time > 20 s, geometry: uniform scanning, reconstruction: filtered back projection. The 600 radiographs were prospectively shown to 3 radiologists. Results: Of the 50 patients with histologically proven breast cancer (BI-RADS™ 6), 39 patients required no further surgical therapy (re-excision) after breast-conserving surgery. A retrospective analysis (n = 11) showed a significant (p < 0.05) increase of sensitivity with the BioVision™, the Trident™ and tomosynthesis compared to the Inspiration™ at a magnification of 1.0 : 2.0 or 1.0 : 1.0 (tomosynthesis) (2.6, 3.3 or 3.6 %), i.e. re-excision would not have been necessary in 2, 3 or 4 patients, respectively, compared to findings obtained with a standard magnification of 1.0 : 1.0. Conclusion: The sensitivity of the BioVision™, the Trident™ and tomosynthesis was significantly (p < 0.05) higher and the rate of re-excisions was reduced compared to FFDM using a conventional detector at a magnification of 2.0 but without zooming.
Aim: This prospective clinical study aimed to evaluate whether it would be possible to reduce the rate of re-excisions using CMOS technology, a specimen radiography system (SRS) or digital breast tomosynthesis (DBT) compared to a conventional full field digital mammography (FFDM) system. Material and Method: Between 12/2012 and 2/2013 50 patients were diagnosed with invasive breast cancer (BI-RADS™ 5). After histological verification, all patients underwent breast-conserving therapy with intraoperative imaging using 4 different systems and differing magnifications: 1. Inspiration™ (Siemens, Erlangen, Germany), amorphous selenium, tungsten source, focus 0.1 mm, resolution 85 µm pixel pitch, 8 lp/mm; 2. BioVision™ (Bioptics, Tucson, AZ, USA), CMOS technology, photodiode array, flat panel, tungsten source, focus 0.05, resolution 50 µm pixel pitch, 12 lp/mm; 3. the Trident™ specimen radiography system (SRS) (Hologic, Bedford, MA, USA), amorphous selenium, tungsten source, focus 0.05, resolution 70 µm pixel pitch, 7.1 lp/mm; 4. tomosynthesis (Siemens, Erlangen, Germany), amorphous selenium, tungsten source, focus 0.1 mm, resolution 85 µm pixel pitch, 8 lp/mm, angular range 50 degrees, 25 projections, scan time > 20 s, geometry: uniform scanning, reconstruction: filtered back projection. The 600 radiographs were prospectively shown to 3 radiologists. Results: Of the 50 patients with histologically proven breast cancer (BI-RADS™ 6), 39 patients required no further surgical therapy (re-excision) after breast-conserving surgery. A retrospective analysis (n = 11) showed a significant (p < 0.05) increase of sensitivity with the BioVision™, the Trident™ and tomosynthesis compared to the Inspiration™ at a magnification of 1.0 : 2.0 or 1.0 : 1.0 (tomosynthesis) (2.6, 3.3 or 3.6 %), i.e. re-excision would not have been necessary in 2, 3 or 4 patients, respectively, compared to findings obtained with a standard magnification of 1.0 : 1.0. Conclusion: The sensitivity of the BioVision™, the Trident™ and tomosynthesis was significantly (p < 0.05) higher and the rate of re-excisions was reduced compared to FFDM using a conventional detector at a magnification of 2.0 but without zooming.
Entities:
Keywords:
Breast; breast cancer; breast malignancy; mammography
Authors: Walter F Good; Gordon S Abrams; Victor J Catullo; Denise M Chough; Marie A Ganott; Christiane M Hakim; David Gur Journal: AJR Am J Roentgenol Date: 2008-04 Impact factor: 3.959
Authors: Matthias W Beckmann; Jens-Uwe Blohmer; Serban-Dan Costa; Klaus Diedrich; Ingo Diel; Wolfgang Eiermann; Klaus Friese; Bernd Gerber; Nadia Harbeck; Joern Hilfrich; Wolfgang Janni; Fritz Jaenicke; Walter Jonat; Manfred Kaufmann; Marion Kiechle; Uwe Koehler; Rolf Kreienberg; Gunter von Minckwitz; Volker Moebus; Ulrike Nitz; Andreas Schneeweiss; Christoph Thomssen; Diethelm Wallwiener Journal: Breast Care (Basel) Date: 2009-04-24 Impact factor: 2.860
Authors: David Gur; Gordon S Abrams; Denise M Chough; Marie A Ganott; Christiane M Hakim; Ronald L Perrin; Grace Y Rathfon; Jules H Sumkin; Margarita L Zuley; Andriy I Bandos Journal: AJR Am J Roentgenol Date: 2009-08 Impact factor: 3.959
Authors: M R Bani; M P Lux; K Heusinger; E Wenkel; A Magener; R Schulz-Wendtland; M W Beckmann; P A Fasching Journal: Eur J Surg Oncol Date: 2008-06-09 Impact factor: 4.424
Authors: Despina Kontos; Predrag R Bakic; Ann-Katherine Carton; Andrea B Troxel; Emily F Conant; Andrew D A Maidment Journal: Acad Radiol Date: 2009-03 Impact factor: 3.173
Authors: R Schulz-Wendtland; P Dankerl; G Dilbat; M Bani; P A Fasching; K Heusinger; M P Lux; C R Loehberg; S M Jud; C Rauh; C M Bayer; M W Beckmann; D L Wachter; M Uder; M Meier-Meitinger; B Brehm Journal: Geburtshilfe Frauenheilkd Date: 2015-01 Impact factor: 2.915
Authors: C C Hack; L Häberle; K Geisler; R Schulz-Wendtland; A Hartmann; P A Fasching; M Uder; D L Wachter; S M Jud; C R Loehberg; M P Lux; C Rauh; M W Beckmann; K Heusinger Journal: Geburtshilfe Frauenheilkd Date: 2013-02 Impact factor: 2.915
Authors: R Schulz-Wendtland; P Dankerl; G Dilbat; M Bani; P A Fasching; K Heusinger; M P Lux; C R Loehberg; S M Jud; C Rauh; C M Bayer; M W Beckmann; M Uder; M Meier-Meitinger; B Brehm Journal: Geburtshilfe Frauenheilkd Date: 2013-11 Impact factor: 2.915